Reese T. Jones, M.D.

Affiliations: 
Psychiatry University of California, San Francisco, San Francisco, CA 
Area:
Drugs of abuse
Google:
"Reese Jones"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Brastianos PK, Carter SL, Santagata S, et al. (2015) Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discovery
Shankar GM, Taylor-Weiner A, Lelic N, et al. (2014) Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathologica Communications. 2: 167
. (2012) Butterfly genome reveals promiscuous exchange of mimicry adaptations among species. Nature. 487: 94-8
Herbst ED, Harris DS, Everhart ET, et al. (2011) Cocaethylene formation following ethanol and cocaine administration by different routes. Experimental and Clinical Psychopharmacology. 19: 95-104
Harris DS, Everhart T, Jacob P, et al. (2009) A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. Bmc Clinical Pharmacology. 9: 13
Mendelson JE, McGlothlin D, Harris DS, et al. (2008) The clinical pharmacology of intranasal l-methamphetamine. Bmc Clinical Pharmacology. 8: 4
Mendelson J, Uemura N, Harris D, et al. (2006) Human pharmacology of the methamphetamine stereoisomers. Clinical Pharmacology and Therapeutics. 80: 403-20
Harris DS, Reus VI, Wolkowitz OM, et al. (2005) Repeated psychological stress testing in stimulant-dependent patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 669-77
Uemura N, Nath RP, Harkey MR, et al. (2004) Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. Journal of Analytical Toxicology. 28: 253-9
Harris DS, Mendelson JE, Lin ET, et al. (2004) Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. Clinical Pharmacokinetics. 43: 329-40
See more...